These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 19541949)

  • 1. Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.
    Parascandola M; Augustson E; O'Connell ME; Marcus S
    Nicotine Tob Res; 2009 Jul; 11(7):886-95. PubMed ID: 19541949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of current and recent former smokers associated with the use of new potential reduced-exposure tobacco products.
    Parascandola M; Augustson E; Rose A
    Nicotine Tob Res; 2009 Dec; 11(12):1431-8. PubMed ID: 19915081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Findings and implications from a national study on potential reduced exposure products (PREPs).
    Hund LM; Farrelly MC; Allen JA; Chou RH; St Claire AW; Vallone DM; Healton CG
    Nicotine Tob Res; 2006 Dec; 8(6):791-7. PubMed ID: 17132527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do Marlboro Lights smokers know about low-tar cigarettes?
    Cummings KM; Hyland A; Bansal MA; Giovino GA
    Nicotine Tob Res; 2004 Dec; 6 Suppl 3():S323-32. PubMed ID: 15799595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic, demographic and smoking-related correlates of the use of potentially reduced exposure to tobacco products in a national sample.
    Shaikh RA; Siahpush M; Singh GK
    Tob Control; 2014 Jul; 23(4):353-8. PubMed ID: 23291431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products.
    Hamilton WL; Norton Gd; Ouellette TK; Rhodes WM; Kling R; Connolly GN
    Nicotine Tob Res; 2004 Dec; 6 Suppl 3():S353-62. PubMed ID: 15799598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of tobacco industry retail marketing activities of reduced harm products.
    Slater S; Giovino G; Chaloupka F
    Nicotine Tob Res; 2008 Jan; 10(1):187-93. PubMed ID: 18188759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoker interest in lower harm alternatives to cigarettes: national survey data.
    Wilson N; Borland R; Weerasekera D; Edwards R; Russell M
    Nicotine Tob Res; 2009 Dec; 11(12):1467-73. PubMed ID: 19828433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Adult Interest in Less Harmful and Less Addictive Hypothetical Modified Risk Tobacco Products.
    O'Brien EK; Persoskie A; Parascandola M; Hoffman AC
    Nicotine Tob Res; 2018 Sep; 20(11):1317-1326. PubMed ID: 29059364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cigarette use and smoking reduction or cessation in the 2010/2011 TUS-CPS longitudinal cohort.
    Shi Y; Pierce JP; White M; Vijayaraghavan M; Compton W; Conway K; Hartman AM; Messer K
    BMC Public Health; 2016 Oct; 16(1):1105. PubMed ID: 27769302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tobacco products: do smokers like them?
    Caraballo RS; Pederson LL; Gupta N
    Tob Control; 2006 Feb; 15(1):39-44. PubMed ID: 16436404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are smokers adequately informed about the health risks of smoking and medicinal nicotine?
    Cummings KM; Hyland A; Giovino GA; Hastrup JL; Bauer JE; Bansal MA
    Nicotine Tob Res; 2004 Dec; 6 Suppl 3():S333-40. PubMed ID: 15799596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoker and ex-smoker reactions to cigarettes claiming reduced risk.
    Shiffman S; Pillitteri JL; Burton SL; Di Marino ME
    Tob Control; 2004 Mar; 13(1):78-84. PubMed ID: 14985602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness and Use of Dissolvable Tobacco Products in the United States.
    Cabrera-Nguyen EP; Cavazos-Rehg P; Krauss M; Kim Y; Emery S
    Nicotine Tob Res; 2016 May; 18(5):857-63. PubMed ID: 26391580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications.
    Pederson LL; Nelson DE
    Nicotine Tob Res; 2007 May; 9(5):525-34. PubMed ID: 17454709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of switching to another tobacco product to quit smoking cigarettes.
    Schauer GL; Malarcher AM; Babb SD
    Nicotine Tob Res; 2015 May; 17(5):622-7. PubMed ID: 25239959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of cigarette packages warning labels in relation to tobacco-smoking dependence and motivation to quit].
    Mannocci A; Antici D; Boccia A; La Torre G
    Epidemiol Prev; 2012; 36(2):100-7. PubMed ID: 22706360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.
    Guydish J; Tajima B; Pramod S; Le T; Gubner NR; Campbell B; Roman P
    Drug Alcohol Depend; 2016 Sep; 166():93-9. PubMed ID: 27449271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers.
    Brown J; West R; Beard E; Michie S; Shahab L; McNeill A
    Addict Behav; 2014 Jun; 39(6):1120-5. PubMed ID: 24679611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.
    Rodu B; Plurphanswat N; Hughes JR; Fagerström K
    Nicotine Tob Res; 2016 May; 18(5):809-16. PubMed ID: 26253616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.